Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo Molecular Therapy; doi.org/10.1016/j.ymthe.2021.04.035 Albert, K., Raymundo, D., Panhelainen, A., et al. (2022)
Molecular Therapy; doi.org/10.1016/j.ymthe.2021.04.035
